Nu Skin Enterprises Stock Discussion

Nu Skin Enterprises' low P/S ratio is likely due to anticipated poor revenue performance. Its shrinking revenues and weak outlook, contrasting with expected industry growth, justify its low P/S ratio and hint at a stagnant share price.

Analysts are more bearish on Nu Skin Enterprises' prospects, with a significant cut to revenue and EPS estimates. The company's slower expected revenue growth compared to the wider market could worry investors.

Despite a mixed Q3, personal care stocks have held their ground better than other sectors, with share prices up 18.5% on average since the previous earnings results. Coty's stock is up 20.9%, Olaplex's stock is up 74.6%, Nu Skin's stock is down 0.1%, Herbalife's stock is down 9.8%, and BellRing Brands' stock is up 22.3%.

Despite challenges, personal care stocks sector showed resilience with average share prices up 20.3%. Nature's Sunshine and Olaplex outperformed, while Nu Skin, USANA, and BeautyHealth underperformed.

Insiders selling shares and the absence of insider purchases last year may indicate a lack of confidence in the company's stock. The absence of purchases this past year could suggest a lack of support.